<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="152861">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01683890</url>
  </required_header>
  <id_info>
    <org_study_id>SBSFSH</org_study_id>
    <nct_id>NCT01683890</nct_id>
  </id_info>
  <brief_title>Study on Bladder and Sexual Function Change After Simple Hysterectomy</brief_title>
  <official_title>Incidence and Pattern of Overactive Bladder Symptoms Occurring After Hysterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Astellas Pharma Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <authority>Korea: Asan Medical Center Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the incidence and pattern of bladder symptoms and sexual function change
      occuring after simple hysterectomy and to analyze the influence of bladder symptoms and
      sexual function change on quality of life of patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Incidence of bladder symptoms</measure>
    <time_frame>within 6 months after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pattern change of bladder symptoms after surgery</measure>
    <time_frame>Baseline and within 6 months after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual function change</measure>
    <time_frame>Baseline and within 6 months after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>within 6 months aftr surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Benign Uterine Disease</condition>
  <arm_group>
    <arm_group_label>Simple hysterectomy group</arm_group_label>
    <description>Patients will undergo simple hysterectomy due to benign uterine disease.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patinets who undergo simple hysterectomy due to benign uterine disease at university
        hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who is planed to undergo simple hysterectomy due to benign uterine disease

               1. Uterine leiomyoma

               2. Uterine adenomyosis

               3. Endometrial hyperplasia

               4. Cervical intraepithelial neoplasia (including carcinoma in situ, FIGO stage IA1
                  cancer)

               5. Dysfunctional uterine bleeding

               6. Other benign uterine disease requiring hysterectomy

        Exclusion Criteria:

          -  Patients who are taking medication for overactive bladder

          -  Patients who underwent incontinence surgery due to urinary incontinence

          -  Acute or chronic infectious disease of urinary tract

          -  Neurologic disease causing urinary abnormality

          -  Previous pelvic radiation therapy

          -  Patients who are undergoing incontinence surgery with hysterectomy

          -  Pregnant woman
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hee-Dong Chae, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hee-Dong Chae, M.D., Ph.D.</last_name>
    <phone>82-2-3010-3649</phone>
    <email>hdchae@amc.seoul.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hee-Dong Chae, M.D., Ph.D.</last_name>
      <phone>82-2-3010-3649</phone>
      <email>hdchae@amc.seoul.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 16, 2012</lastchanged_date>
  <firstreceived_date>September 4, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Hee-Dong Chae</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Bladder symptoms</keyword>
  <keyword>Sexual function</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Simple hysterectomy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Uterine Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
